Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers
Cancer, 05/21/2012But Z et al.
The National Comprehensive Cancer Network (NCCN)–Functional Assessment of Cancer Therapy–Hepatobiliary (FACT) Hepatobiliary–Pancreatic Symptom Index (NFHSI–18) assesses symptoms of importance to patients with hepatobiliary and pancreatic cancers and demonstrates promising measurement properties. The scale is a good candidate for brief symptom assessment in clinical trials.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.